Apogee Therapeutics

👥 101-250💰 $149.0m Series B on 2022-12-07BiotechnologyTherapeuticsMedicalLife Science
Website LinkedIn

Apogee Therapeutics is a San Francisco-based biotechnology company, established in 2022, focused on developing innovative therapies for immunological and inflammatory disorders to meet patient needs.